Milestone Pharmaceuticals Statistics
Total Valuation
MIST has a market cap or net worth of $126.85 million. The enterprise value is $110.08 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MIST has 66.24 million shares outstanding. The number of shares has increased by 31.53% in one year.
Current Share Class | 53.33M |
Shares Outstanding | 66.24M |
Shares Change (YoY) | +31.53% |
Shares Change (QoQ) | +0.04% |
Owned by Insiders (%) | 0.73% |
Owned by Institutions (%) | 43.40% |
Float | 52.85M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 5.52 |
P/TBV Ratio | 5.52 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.40, with a Debt / Equity ratio of 2.25.
Current Ratio | 15.40 |
Quick Ratio | 14.91 |
Debt / Equity | 2.25 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -12.38 |
Financial Efficiency
Return on equity (ROE) is -162.87% and return on invested capital (ROIC) is -34.55%.
Return on Equity (ROE) | -162.87% |
Return on Assets (ROA) | -32.06% |
Return on Capital (ROIC) | -34.55% |
Revenue Per Employee | n/a |
Profits Per Employee | -$909,936 |
Employee Count | 47 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.23% in the last 52 weeks. The beta is 1.84, so MIST's price volatility has been higher than the market average.
Beta (5Y) | 1.84 |
52-Week Price Change | -37.23% |
50-Day Moving Average | 1.63 |
200-Day Moving Average | 1.57 |
Relative Strength Index (RSI) | 70.85 |
Average Volume (20 Days) | 584,290 |
Short Selling Information
The latest short interest is 438,272, so 0.66% of the outstanding shares have been sold short.
Short Interest | 438,272 |
Short Previous Month | 454,790 |
Short % of Shares Out | 0.66% |
Short % of Float | 0.83% |
Short Ratio (days to cover) | 2.46 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -43.55M |
Pretax Income | -48.41M |
Net Income | -42.77M |
EBITDA | -43.45M |
EBIT | -43.55M |
Earnings Per Share (EPS) | -$0.76 |
Full Income Statement Balance Sheet
The company has $76.42 million in cash and $54.02 million in debt, giving a net cash position of $22.40 million or $0.34 per share.
Cash & Cash Equivalents | 76.42M |
Total Debt | 54.02M |
Net Cash | 22.40M |
Net Cash Per Share | $0.34 |
Equity (Book Value) | 24.01M |
Book Value Per Share | 0.36 |
Working Capital | 75.73M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$31.80 million and capital expenditures -$42,000, giving a free cash flow of -$31.84 million.
Operating Cash Flow | -31.80M |
Capital Expenditures | -42,000 |
Free Cash Flow | -31.84M |
FCF Per Share | -$0.48 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MIST does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -31.53% |
Shareholder Yield | -31.53% |
Earnings Yield | -32.28% |
FCF Yield | -24.04% |
Analyst Forecast
The average price target for MIST is $13.00, which is 578.85% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $13.00 |
Price Target Difference | 578.85% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 196.96% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MIST has an Altman Z-Score of -5.64 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.64 |
Piotroski F-Score | 2 |